
Current Price | $35.68 | Mkt Cap | $3.0B |
---|---|---|---|
Open | $36.10 | P/E Ratio | 0.00 |
Prev. Close | $35.68 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $34.28 - $37.52 | Volume | 680,116 |
52-Wk Range | $10.94 - $40.01 | Avg. Daily Vol. | 692,682 |
Current Price | $35.68 | Mkt Cap | $3.0B |
---|---|---|---|
Open | $36.10 | P/E Ratio | 0.00 |
Prev. Close | $35.68 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $34.28 - $37.52 | Volume | 680,116 |
52-Wk Range | $10.94 - $40.01 | Avg. Daily Vol. | 692,682 |
The best Bull and Bear pitches based on recency and number of recommendations.
I like Intra-Cellular's position despite the recent massive pullback. After strong enough phase III data from the first schizophrenia trial to support FDA approval, data from the second phase III trial is expected in mid 2016. The company has also… More
Ran up to much. HUGE secondary offering on the way. 1/3 of it's market cap. Underwriters have been pumping. Seeing this stock on it's way to a major crash. Short-Term PT of under 30
Read the most recent pitches from players about ITCI.
Recs
The company focuses on difficult-to-treat diseases like schizophrenia and dementia, and its first drug was recently approved for sale.
Recs
Was I lucky green-thumbing ITCI just before FDA approval? Well now that it's over I can pretty much say whatever I want. So, no, it was just savvy investing. I do better predicting FDA decisions than post approval sales. Seems regardless of market size or marketing muscle, it's a crapshoot for me whether the drug will take off. So here we are. ITCI has a new class of drug in a huge indication. I'm hanging on expecting big things. Tell me what I'm missing.
Recs
New drug for bipolar disorder looks as close to a sure thing as there can be going into an FDA decision date of December 278th or sooner, 2019.
Find the members with the highest scoring picks in ITCI.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
odocoileus | 82.14 | 12/11/2019 |
![]() |
5Y | $12.32 | +189.61% | +21.80% | +167.81 | 1 Comment | |
emtking | 60.22 | 12/13/2019 |
![]() |
5Y | $12.60 | +183.17% | +20.42% | +162.75 | 1 Comment | |
![]() |
km00nster | 81.08 | 9/21/2015 |
![]() |
5Y | $50.63 | -29.53% | +95.08% | +124.60 | 1 Comment |
Hendrickson71 | < 20 | 1/7/2016 |
![]() |
3W | $48.05 | -25.74% | +95.74% | +121.48 | 1 Comment | |
stockgripes | 98.99 | 9/16/2015 |
![]() |
5Y | $45.15 | -20.97% | +91.44% | +112.42 | 1 Comment | |
derbydog85 | 61.24 | 12/23/2016 |
![]() |
5Y | $15.62 | +128.43% | +69.56% | +58.86 | 0 Comment | |
Dananator | 53.44 | 8/7/2020 |
![]() |
5Y | $20.97 | +70.19% | +14.44% | +55.75 | 0 Comment | |
joe508mama | 30.75 | 9/30/2016 |
![]() |
5Y | $15.41 | +131.54% | +77.29% | +54.25 | 0 Comment | |
warrenout | 28.87 | 9/30/2016 |
![]() |
3M | $15.41 | +131.54% | +77.29% | +54.25 | 0 Comment | |
jmdor2222 | 80.29 | 9/29/2016 |
![]() |
5Y | $15.49 | +130.34% | +77.40% | +52.94 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.